America’s EV Supply Chain In Doubt
China set up to be America’s Green OPEC. Experts warn The Hill that the supply chain to make EV batteries is out of our hands.
CPA response to Wyden-Brown-Warner International Taxation Overhaul Framework
On April 23, 2021, the Coalition for a Prosperous America responded to the request for comments by the staff of the Senate Finance Committee regarding
Sen. Bob Casey Thinks Tariffs Should Stay, TPP Is RIP, And Makes The Case For Reshoring
Sen. Bob Casey gave the equivalent of a TED Talk on the China challenge facing the American manufacturer, calling for keeping tariffs and working with allies. On Biden’s Buy Clean, he says nix China.
USTR Counterfeit Imports Review Shows It’s Almost All China; Here’s One Way To Stop It
U.S. consumers might not always suffer. But any company in the U.S., including small and large retail stores, will increasingly be competing in a new B2C digital model that connects American consumers directly to China.
Latest Round of China Bills: Financial Markets on Notice, Plus Diplomatic Olympic Boycott
A new round of Congressional legislation targets China. Will they pass? And when they do, will the government take action, or issue endless reviews and investigations as China marches on, and America risks stalling out post-pandemic.
Yellen’s Failure on Currency Manipulation: “What She Said. What She Did.”
Yellen takes a pass on calling Vietnam, others, currency manipulators. That puts the onus on Commerce and the USTR to do something about it. Will they?
Senator Wyden Faces Obstacles To Permanent Clean Energy Tax Break Plan
Worried about climate change, Senator Wyden and the Democrats want to give cleantech and energy companies permanent tax breaks. He faces some serious opposition.
From Climate to China Dependency, Remapping Supply Chains Gains Traction Among Big Business
McKinsey has turned the corner on the Asia-centric model of globalization. It’s a “now-or-never” moment for US manufacturing. Here’s where CPA sees eye-to-eye.
How Made in China 2025 Will Be Partially Funded By Wall Street
From retail investors in China ETFs, to Wall Street’s largest investment firms, China’s new technologies can always count on tens of millions of dollars of inflows from Americans. What do we get in return?
Making The Case For Reshoring Critical Drugs, Where 90% Of Inputs Are In China’s Hands
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
